CytRx Corporation (CYTR) Issues Letter to Stockholders Providing Business Update
5/20/2013 10:25:35 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, announced the issuance of its annual Letter to Stockholders from President and CEO Steven A. Kriegsman. The Letter provides an overview of the Company’s business plan and is available on the Company’s website at www.cytrx.com. Excerpts from the Letter are as follows:
Help employers find you! Check out all the jobs and post your resume.
comments powered by